Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023)
Pharvaris (PHVS) reported Other Non-Current Assets of $667959.6 for Q4 2023, up 12.38% on a YoY basis from $594384.9 in Q4 2022, and up 12.38% quarter-over-quarter from $594384.9 in Q4 2022.
Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023) Analysis & Trends
Pharvaris has reported Other Non-Current Assets for 4 years, with the latest figure at $667959.6 in Q4 2023.
- For the quarter ending Q4 2023, Other Non-Current Assets rose 12.38% year-over-year to $667959.6; the trailing twelve-month figure through Dec 2023 stood at $667959.6 (up 12.38% YoY), and the FY2023 full-year result was $671546.5, up 9.37% from the prior year.
- Other Non-Current Assets for Q4 2023 stood at $667959.6, up from $594384.9 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.4 million in Q4 2020, with the low at $6519.5 in Q4 2021.
- Historically, Other Non-Current Assets has averaged $678666.4 across 4 years, with a median of $631172.3 in 2022.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets sank 99.55% — and 2022, when it jumped 9017.05%.
- Pharvaris' Other Non-Current Assets stood at $1.4 million in 2020, then slumped by 99.55% to $6519.5 in 2021, then jumped by 9017.05% to $594384.9 in 2022, then increased by 12.38% to $667959.6 in 2023.
- The last three Other Non-Current Assets figures came in at $667959.6 (Q4 2023), $594384.9 (Q4 2022), and $6519.5 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 667,959.63 |
| Dec 31, 2022 | 594,384.89 |
| Dec 31, 2021 | 6,519.49 |
| Dec 31, 2020 | 1.45 Mn |